CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression

被引:13
|
作者
McCloskey, TW
Oyaizu, N
Bakshi, S
Kowalski, R
Kohn, N
Pahwa, S
机构
[1] NYU, N Shore Univ Hosp, Sch Med, Dept Pediat,Div Allergy Immunol, Manhasset, NY 11030 USA
[2] NYU, N Shore Univ Hosp, Sch Med, Dept Res,Div Biostat, Manhasset, NY 11030 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1998年 / 87卷 / 01期
基金
美国国家卫生研究院;
关键词
CD95; apoptosis; HIV; infants;
D O I
10.1006/clin.1997.4496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pediatric HIV infection is characterized by a progressive decline in CD4 T lymphocytes and faster disease progression than is typically seen in adults. Apoptosis, possibly mediated through the CD95 antigen, has been proposed as a mechanism for cell loss which eventually leads to immune dysfunction. In this study of peripheral blood lymphocytes from HIV-infected children, classified according to CDC immunologic categories, we found that the percentage of CD4 and CD8 T cells expressing CD95 and the percentage of lymphocytes undergoing apoptosis were increased in children with HIV infection and were greater in children from immunologic Category III as compared to those in Category I. Most striking was our observation that an increased percentage of CD95-positive cells appeared as early as 3 months of age, at a time when these children did not have elevated levels of apoptosis. These data demonstrate early upregulation of CD95 expression in HIV-infected infants, an abberation which may have profound implications for the pathogenesis of perinatally acquired IIIV disease. (C) 1998 Academic Press.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [21] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [22] Fas/APO-1 (CD95) expression in myelodysplastic syndromes
    Lepelley, P
    Grardel, N
    Erny, O
    Iaru, T
    Obein, V
    Cosson, A
    Fenaux, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) : 307 - 312
  • [23] Apoptosis in neuroblastomas induced by interferon-γ involves the CD95/CD95L pathway
    Annicchiarico-Petruzzelli, M
    Bernassola, F
    Lovat, PE
    Redfern, CPF
    Pearson, ADJ
    Melino, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01): : 115 - 117
  • [24] CD95 signaling in colorectal cancer
    Hoogwater, Frederik J. H.
    Steller, Ernst J. A.
    Westendorp, B. Florien
    Rinkes, Inne H. M. Borel
    Kranenburg, Onno
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (01): : 189 - 198
  • [25] Cytotoxic drugs and the CD95 pathway
    C Friesen
    S Fulda
    K-M Debatin
    Leukemia, 1999, 13 : 1854 - 1858
  • [26] CD95 is not functional in human erythrocytes
    Sagan, D.
    Jermnim, N.
    Tangvarasittichai, O.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) : E244 - E247
  • [27] CD95 in cancer: tool or target?
    Martin-Villalba, Ana
    Llorens-Bobadilla, Enric
    Wollny, Damian
    TRENDS IN MOLECULAR MEDICINE, 2013, 19 (06) : 329 - 335
  • [28] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    D Bouscary
    J De Vos
    M Guesnu
    K Jondeau
    F Viguier
    J Melle
    F Picard
    F Dreyfus
    M Fontenay-Roupie
    Leukemia, 1997, 11 : 839 - 845
  • [29] Fas antigen (CD95) expression and apoptosis in hepatocytes of patients with chronic viral hepatitis
    Kiyici, M
    Gurel, S
    Budak, F
    Dolar, E
    Gulten, M
    Nak, SG
    Memik, F
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (10) : 1079 - 1084
  • [30] Fas receptor (CD95)-mediated apoptosis in leukemic cells
    Komada, Y
    Sakurai, M
    LEUKEMIA & LYMPHOMA, 1997, 25 (1-2) : 9 - 21